CWP
INSM icon

Concord Wealth Partners’s Insmed INSM Stock Holding History

Concord Wealth Partners’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$174 – 483
2025
Q4 		$174 Hold
1
– – ﹤0.01% 808
2025
Q3 		$144 Hold
1
– – ﹤0.01% 798
2025
Q2 		$101 Buy
+1
New +$76 ﹤0.01% 834
2021
Q1 		– Sell
-55
Closed -$2K – 1030
2020
Q4 		$2K Buy
+55
New +$2.01K ﹤0.01% 534

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Concord Wealth Partners's INSM Position: Q1 2026 in Review

Concord Wealth Partners sold out of Insmed (INSM) in Q1 2026, closing a stake of 1 share — an estimated $174 sold.

Concord Wealth Partners first reported a position in INSM in Q4 2020 and held it in 4 quarters. The position peaked at $2K in Q4 2020. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Concord Wealth Partners reported no remaining Insmed position as of Q1 2026 after selling out during the quarter.
  • Concord Wealth Partners sold 1 Insmed share in Q1 2026, an estimated $174.
  • Concord Wealth Partners first reported a position in Insmed in Q4 2020 and held it in 4 quarters.
  • Concord Wealth Partners's Insmed position peaked at $2K in Q4 2020.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Concord Wealth Partners's 13F filing for Q1 2026, filed 1 May 2026.